Oncolytics Biotech (oncy) Misses Q3 EPS by 25c

Oncolytics Biotech (NASDAQ: oncy) reported Q3 EPS of ($0.02), $0.25 worse than the analyst estimate of $0.23.

For earnings history and earnings-related data on Oncolytics Biotech (oncy) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Teva Pharma (TEVA) at Outperform
• JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral